Dr. Barr, a cardiologist by training, earned his medical degree from Sidney Kimmel Medical College, part of Philadelphia-based Thomas Jefferson University. Since joining Merck in 1995, Dr. Barr has held numerous leadership roles in oncology and infectious diseases clinical development. He oversaw the development of Merck’s human papillomavirus vaccine and is currently the senior vice president of global clinical development at Merck.
Before joining Merck, Dr. Barr was a faculty member at the University of Chicago. He succeeds Roy Baynes, MD, PhD, who is retiring from his role as head of global clinical development and CMO in July.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.